314 related articles for article (PubMed ID: 24606313)
21. Epidermal growth factor receptor inhibitor ameliorates excessive astrogliosis and improves the regeneration microenvironment and functional recovery in adult rats following spinal cord injury.
Li ZW; Li JJ; Wang L; Zhang JP; Wu JJ; Mao XQ; Shi GF; Wang Q; Wang F; Zou J
J Neuroinflammation; 2014 Apr; 11():71. PubMed ID: 24708754
[TBL] [Abstract][Full Text] [Related]
22. Fibrinogen triggers astrocyte scar formation by promoting the availability of active TGF-beta after vascular damage.
Schachtrup C; Ryu JK; Helmrick MJ; Vagena E; Galanakis DK; Degen JL; Margolis RU; Akassoglou K
J Neurosci; 2010 Apr; 30(17):5843-54. PubMed ID: 20427645
[TBL] [Abstract][Full Text] [Related]
23. KCa3.1 ion channel: A novel therapeutic target for corneal fibrosis.
Anumanthan G; Gupta S; Fink MK; Hesemann NP; Bowles DK; McDaniel LM; Muhammad M; Mohan RR
PLoS One; 2018; 13(3):e0192145. PubMed ID: 29554088
[TBL] [Abstract][Full Text] [Related]
24. Blockade of KCa3.1: A novel target to treat TGF-β1 induced conjunctival fibrosis.
Anumanthan G; Wilson PJ; Tripathi R; Hesemann NP; Mohan RR
Exp Eye Res; 2018 Feb; 167():140-144. PubMed ID: 29242028
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of the Ca²⁺-dependent K⁺ channel, KCNN4/KCa3.1, improves tissue protection and locomotor recovery after spinal cord injury.
Bouhy D; Ghasemlou N; Lively S; Redensek A; Rathore KI; Schlichter LC; David S
J Neurosci; 2011 Nov; 31(45):16298-308. PubMed ID: 22072681
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of Interleukin 10 Transcription through the SMAD2/3 Signaling Pathway by Ca
Matsui M; Kajikuri J; Kito H; Endo K; Hasegawa Y; Murate S; Ohya S
Mol Pharmacol; 2019 Mar; 95(3):294-302. PubMed ID: 30622214
[TBL] [Abstract][Full Text] [Related]
27. The potassium channel KCa3.1 as new therapeutic target for the prevention of obliterative airway disease.
Hua X; Deuse T; Chen YJ; Wulff H; Stubbendorff M; Köhler R; Miura H; Länger F; Reichenspurner H; Robbins RC; Schrepfer S
Transplantation; 2013 Jan; 95(2):285-92. PubMed ID: 23325003
[TBL] [Abstract][Full Text] [Related]
28. Early activation of STAT3 regulates reactive astrogliosis induced by diverse forms of neurotoxicity.
O'Callaghan JP; Kelly KA; VanGilder RL; Sofroniew MV; Miller DB
PLoS One; 2014; 9(7):e102003. PubMed ID: 25025494
[TBL] [Abstract][Full Text] [Related]
29. Involvement of p38 MAPK in reactive astrogliosis induced by ischemic stroke.
Roy Choudhury G; Ryou MG; Poteet E; Wen Y; He R; Sun F; Yuan F; Jin K; Yang SH
Brain Res; 2014 Mar; 1551():45-58. PubMed ID: 24440774
[TBL] [Abstract][Full Text] [Related]
30. The KCa3.1 blocker TRAM-34 inhibits proliferation of fibroblasts in paraquat-induced pulmonary fibrosis.
Xie H; Lu J; Zhu Y; Meng X; Wang R
Toxicol Lett; 2018 Oct; 295():408-415. PubMed ID: 30036685
[TBL] [Abstract][Full Text] [Related]
31. Astrocyte elevated gene-1 regulates astrocyte responses to neural injury: implications for reactive astrogliosis and neurodegeneration.
Vartak-Sharma N; Ghorpade A
J Neuroinflammation; 2012 Aug; 9():195. PubMed ID: 22884085
[TBL] [Abstract][Full Text] [Related]
32. K
Lu R; Flauaus C; Kennel L; Petersen J; Drees O; Kallenborn-Gerhardt W; Ruth P; Lukowski R; Schmidtko A
Neuropharmacology; 2017 Oct; 125():386-395. PubMed ID: 28823609
[TBL] [Abstract][Full Text] [Related]
33. Treatment with the KCa3.1 inhibitor TRAM-34 during diabetic ketoacidosis reduces inflammatory changes in the brain.
Glaser N; Little C; Lo W; Cohen M; Tancredi D; Wulff H; O'Donnell M
Pediatr Diabetes; 2017 Aug; 18(5):356-366. PubMed ID: 27174668
[TBL] [Abstract][Full Text] [Related]
34. An in vitro model of reactive astrogliosis and its effect on neuronal growth.
Yu P; Wang H; Katagiri Y; Geller HM
Methods Mol Biol; 2012; 814():327-40. PubMed ID: 22144316
[TBL] [Abstract][Full Text] [Related]
35. Astrogliosis in culture: I. The model and the effect of antisense oligonucleotides on glial fibrillary acidic protein synthesis.
Yu AC; Lee YL; Eng LF
J Neurosci Res; 1993 Feb; 34(3):295-303. PubMed ID: 8455207
[TBL] [Abstract][Full Text] [Related]
36. K
Pang ZD; Wang Y; Wang XJ; She G; Ma XZ; Song Z; Zhao LM; Wang HF; Lai BC; Gou W; Du XJ; Deng XL
FASEB J; 2019 Dec; 33(12):14760-14771. PubMed ID: 31690106
[TBL] [Abstract][Full Text] [Related]
37. The metabesity factor HMG20A potentiates astrocyte survival and reactive astrogliosis preserving neuronal integrity.
Lorenzo PI; Martin Vazquez E; López-Noriega L; Fuente-Martín E; Mellado-Gil JM; Franco JM; Cobo-Vuilleumier N; Guerrero Martínez JA; Romero-Zerbo SY; Perez-Cabello JA; Rivero Canalejo S; Campos-Caro A; Lachaud CC; Crespo Barreda A; Aguilar-Diosdado M; García Fuentes E; Martin-Montalvo A; Álvarez Dolado M; Martin F; Rojo-Martinez G; Pozo D; Bérmudez-Silva FJ; Comaills V; Reyes JC; Gauthier BR
Theranostics; 2021; 11(14):6983-7004. PubMed ID: 34093866
[No Abstract] [Full Text] [Related]
38. Blockade of the intermediate-conductance Ca(2+)-activated K+ channel inhibits the angiogenesis induced by epidermal growth factor in the treatment of corneal alkali burn.
Yang H; Li X; Ma J; Lv X; Zhao S; Lang W; Zhang Y
Exp Eye Res; 2013 May; 110():76-87. PubMed ID: 23482085
[TBL] [Abstract][Full Text] [Related]
39. Traumatic scratch injury in astrocytes triggers calcium influx to activate the JNK/c-Jun/AP-1 pathway and switch on GFAP expression.
Gao K; Wang CR; Jiang F; Wong AY; Su N; Jiang JH; Chai RC; Vatcher G; Teng J; Chen J; Jiang YW; Yu AC
Glia; 2013 Dec; 61(12):2063-77. PubMed ID: 24123203
[TBL] [Abstract][Full Text] [Related]
40. Blocking epidermal growth factor receptor attenuates reactive astrogliosis through inhibiting cell cycle progression and protects against ischemic brain injury in rats.
Yang Q; Wang EY; Huang XJ; Qu WS; Zhang L; Xu JZ; Wang W; Tian DS
J Neurochem; 2011 Nov; 119(3):644-53. PubMed ID: 21883215
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
